Could a new drug tame the immune chaos of long COVID POTS?
NCT ID NCT07189936
First seen Nov 01, 2025 · Last updated May 29, 2026 · Updated 30 times
Summary
This study tests whether a drug called 2-HOBA can reduce immune system overactivity in people with Long COVID-related POTS, a condition causing rapid heart rate, fatigue, and dizziness. Researchers will give 50 participants either 2-HOBA or a placebo for 28 days to see if it lowers inflammatory markers and improves symptoms. The goal is to find a treatment that eases the persistent immune response driving these long-term symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cyndya Shibao
RECRUITINGNashville, Tennessee, 37027, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.